Kit and Scl regulation of hematopoietic stem cells

Current Opinion in Hematology

Volumn 21, Issue 4, 2014, Pages 256-264

  Rojas Sutterlin, Shanti ^a,b   Lecuyer, Eric ^c,d   Hoang, Trang ^a,b,d  

^a INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^d Department of Biochemistry ^*  (Canada)

Author keywords

Feedforward loop; Hematopoietic stem cells; KIT; SCL TAL1; Self renewal

Indexed keywords

DNA; PROTEIN TYROSINE PHOSPHATASE SHP 2; PROTEOME; STEM CELL FACTOR; TRANSCRIPTION FACTOR TAL1; TRANSCRIPTOME; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; ONCOPROTEIN; STEM CELL FACTOR RECEPTOR; TAL1 PROTEIN, HUMAN;

CELL DIVISION; CELL QUIESCENCE; CELL SURVIVAL; CELL THERAPY; CELLULAR PARAMETERS; DNA BINDING; ERYTHROBLAST; GENE INTERACTION; GENETICS; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC SYSTEM; HUMAN; MOLECULAR MECHANICS; NONHUMAN; PATHOPHYSIOLOGY; POLYCYTHEMIA VERA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REVIEW; SELF CONCEPT; ANIMAL; CELL CYCLE; CELL DIFFERENTIATION; CYTOLOGY; EPISTASIS; HEMATOPOIESIS; METABOLISM; PHYSIOLOGY; TRANSCRIPTION INITIATION;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL CYCLE; CELL DIFFERENTIATION; CELL SURVIVAL; EPISTASIS, GENETIC; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; PROMOTER REGIONS, GENETIC; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-KIT; STEM CELL FACTOR; TRANSCRIPTIONAL ACTIVATION;

EID: 84902253814     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0000000000000052     Document Type: Review

References (75)

1. Lacombe J, Krosl G, Tremblay M, et al. Genetic interaction between Kit and Scl. Blood 2013; 122:1150-1161.
2. Zhu HH, Ji K, Alderson N, et al. Kit-Shp2-Kit signaling acts to maintain a functional hematopoietic stem and progenitor cell pool. Blood 2011; 117:5350-5361.
3. Benveniste P, Frelin C, Janmohamed S, et al. Intermediate-term hematopoietic stem cells with extended but time-limited reconstitution potential. Cell Stem Cell 2010; 6:48-58.
4. Sanjuan-Pla A, Macaulay IC, Jensen CT, et al. Platelet-biased stem cells reside at the apex of the haematopoietic stem-cell hierarchy. Nature 2013; 502:232-236.
5. Little CC. The relation of yellow coat color and black-eyed white spotting of mice in inheritance. Genetics 1917; 2:433-444.
6. McCulloch EA, Siminovitch L, Till JE. Spleen-colony formation in anemic mice of genotype Ww. Science 1964; 144:844-846.
7. Yarden Y, Kuang WJ, Yang-Feng T, et al. Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J 1987; 6:3341-3351.
8. Chabot B, Stephenson DA, Chapman VM, et al. The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus. Nature 1988; 335:88-89.
9. Huang E, Nocka K, Beier DR, et al. The hematopoietic growth factor KL is encoded by the Sl locus and is the ligand of the c-kit receptor, the gene product of the W locus. Cell 1990; 63:225-233.
10. Zsebo KM, Williams DA, Geissler EN, et al. Stem cell factor is encoded at the Sl locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 1990; 63:213-224.
11. Williams DE, Eisenman J, Baird A, et al. Identification of a ligand for the c-kit proto-oncogene. Cell 1990; 63:167-174.
12. Carow CE, Hangoc G, Cooper SH, et al. Mast cell growth factor (c-kit ligand) supports the growth of human multipotential progenitor cells with a high replating potential. Blood 1991; 78:2216-2221.
13. Brannan CI, Lyman SD, Williams DE. Steel-Dickie mutation encodes a c-kit ligand lacking transmembrane and cytoplasmic domains. Proc Natl Acad Sci USA 1991; 88:4671-4674.
14. Kunisaki Y, Bruns I, Scheiermann C, et al. Arteriolar niches maintain haematopoietic stem cell quiescence. Nature 2013; 502:637-643.
15. Ding L, Saunders TL, Enikolopov G, et al. Endothelial and perivascular cells maintain haematopoietic stem cells. Nature 2012; 481:457-462.
16. Ding L, Morrison SJ. Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches. Nature 2013; 495:231-235.
17. Lander AD, Kimble J, Clevers H, et al. What does the concept of the stem cell niche really mean today? BMC Biol 2012; 10:19.
18. Miller CL, Rebel VI, Lemieux ME, et al. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells. Exp Hematol 1996; 24:185-194.
19. Bowie MB, Kent DG, Dykstra B, et al. Identification of a new intrinsically timed developmental checkpoint that reprograms key hematopoietic stem cell properties. Proc Natl Acad Sci USA 2007; 104:5878-5882.
20. Wilson A, Laurenti E, Oser G, et al. Hematopoietic stemcells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell 2008; 135:1118-1129.
21. Thoren LA, Liuba K, Bryder D, et al. Kit regulates maintenance of quiescent hematopoietic stem cells. J Immunol 2008; 180:2045-2053.
22. Lin KK, Rossi L, Boles NC, et al. CD81 is essential for the re-entry of hematopoietic stem cells to quiescence following stress-induced proliferation via deactivation of the Akt pathway. PLoS Biol 2011; 9:e1001148.
23. Anzai N, Lee Y, Youn BS, et al. c-Kit associated with the transmembrane 4 superfamily proteins constitutes a functionally distinct subunit in human hematopoietic progenitors. Blood 2002; 99:4413-4421.
24. Chatr-Aryamontri A, Breitkreutz BJ, Heinicke S, et al. The BioGRID interaction database: 2013 update. Nucleic Acids Res 2013; 41:D816-D823.
25. Breitkreutz BJ, Stark C, Tyers M. Osprey: a network visualization system. Genome Biol 2003; 4:R22.
26. Rojas-Sutterlin S, Hoang T. Hematopoietic stem cell quiescence and long term maintenance: role of SCL/TAL1. In: Hayat MA, editor. Tumor dormancy and cellular quiescence. V. The Netherlands: Springer Science Company; 2013. pp. 87-105.
27. Goldberg LR, Dooner MS, Johnson KW, et al. The murine long-term multilineage renewal marrow stem cell is a cycling cell. Leukemia 2013; 28:813-822.
28. Matsuoka Y, Sasaki Y, Nakatsuka R, et al. Low level of c-kit expression marks deeply quiescent murine hematopoietic stem cells. Stem Cells 2011; 29:1783-1791.
29. Shin JY, Hu W, Naramura M, et al. High c-Kit expression identifies hematopoietic stem cells with impaired self-renewal and megakaryocytic bias. J Exp Med 2014; 211:217-231.
30. Wu H, Klingmuller U, Acurio A, et al. Functional interaction of erythropoietin and stem cell factor receptors is essential for erythroid colony formation. Proc Natl Acad Sci USA 1997; 94:1806-1810.
31. Jahn T, Sindhu S, Gooch S, et al. Direct interaction between Kit and the interleukin-7 receptor. Blood 2007; 110:1840-1847.
32. Zhu MJ, Ou WB, Fletcher CD, et al. KIT oncoprotein interactions in gastrointestinal stromal tumors: therapeutic relevance. Oncogene 2007; 26:6386-6395.
33. Park GH, Plummer HK 3rd, Krystal GW. Selective Sp1 binding is critical for maximal activity of the human c-kit promoter. Blood 1998; 92:4138-4149.
34. Ratajczak MZ, Perrotti D, Melotti P, et al. Myb and ets proteins are candidate regulators of c-kit expression in human hematopoietic cells. Blood 1998; 91:1934-1946.
35. Krosl G, He G, Lefrancois M, et al. Transcription factor SCL is required for ckit expression and c-Kit function in hemopoietic cells. J Exp Med 1998; 188:439-450.
36. Lecuyer E, Herblot S, Saint-Denis M, et al. The SCL complex regulates c-kit expression in hematopoietic cells through functional interaction with Sp1. Blood 2002; 100:2430-2440.
37. El Omari K, Hoosdally SJ, Tuladhar K, et al. Structural basis for LMO2-driven recruitment of the SCL:E47bHLH heterodimer to hematopoietic-specific transcriptional targets. Cell Rep 2013; 4:135-147.
38. Fujiwara T, Lee HY, Sanalkumar R, et al. Building multifunctionality into a complex containing master regulators of hematopoiesis. Proc Natl Acad Sci USA 2010; 107:20429-20434.
39. Kassouf MT, Hughes JR, Taylor S, et al. Genome-wide identification of TAL1s functional targets: insights into its mechanisms of action in primary erythroid cells. Genome Res 2010; 20:1064-1083.
40. Wilson NK, Foster SD, Wang X, et al. Combinatorial transcriptional control in blood stem/progenitor cells: genome-wide analysis of ten major transcriptional regulators. Cell Stem Cell 2010; 7:532-544.
41. Ciau-Uitz A, Pinheiro P, Kirmizitas A, et al. VEGFA-dependent and -independent pathways synergise to drive Scl expression and initiate programming of the blood stem cell lineage in Xenopus. Development 2013; 140:2632-2642.
42. Van Handel B, Montel-Hagen A, Sasidharan R, et al. Scl represses cardiomyogenesis in prospective hemogenic endothelium and endocardium. Cell 2012; 150:590-605.
43. Mikkola HK, Klintman J, Yang H, et al. Haematopoietic stem cells retain longterm repopulating activity and multipotency in the absence of stem-cell leukaemia SCL/tal-1 gene. Nature 2003; 421:547-551.
44. Curtis DJ, Hall MA, Van Stekelenburg LJ, et al. SCL is required for normal function of short-term repopulating hematopoietic stem cells. Blood 2004; 103:3342-3348.
45. Lacombe J, Herblot S, Rojas-Sutterlin S, et al. Scl regulates the quiescence and the long-term competence of hematopoietic stem cells. Blood 2010; 115:792-803.
46. Brunet de la Grange P, Armstrong F, Duval V, et al. Low SCL/TAL1 expression reveals its major role in adult hematopoietic myeloid progenitors and stem cells. Blood 2006; 108:2998-3004.
47. Reynaud D, Ravet E, Titeux M, et al. SCL/TAL1 expression level regulates human hematopoietic stem cell self-renewal and engraftment. Blood 2005; 106:2318-2328.
48. Calkhoven CF, Muller C, Martin R, et al. Translational control of SCL-isoform expression in hematopoietic lineage choice. Genes Dev 2003; 17:959-964.
49. Aplan PD, Begley CG, Bertness V, et al. The SCL gene is formed from a transcriptionally complex locus. Mol Cell Biol 1990; 10:6426-6435.
50. Ren X, Gomez GA, Zhang B, et al. Scl isoforms act downstream of etsrp to specify angioblasts and definitive hematopoietic stem cells. Blood 2010; 115:5338-5346.
51. Schlaeger TM, Schuh A, Flitter S, et al. Decoding hematopoietic specificity in the helix-loop-helix domain of the transcription factor SCL/Tal-1. Mol Cell Biol 2004; 24:7491-7502.
52. Hall MA, Curtis DJ, Metcalf D, et al. The critical regulator of embryonic hematopoiesis, SCL, is vital in the adult for megakaryopoiesis, erythropoiesis, and lineage choice in CFU-S12. Proc Natl Acad Sci USA 2003; 100:992-997.
53. Aplan PD, Nakahara K, Orkin SH, et al. The SCL gene product: a positive regulator of erythroid differentiation. EMBO J 1992; 11:4073-4081.
54. Palii CG, Perez-Iratxeta C, Yao Z, et al. Differential genomic targeting of the transcription factor TAL1 in alternate haematopoietic lineages. EMBO J 2011; 30:494-509.
55. Anguita E, Hughes J, Heyworth C, et al. Globin gene activation during haemopoiesis is driven by protein complexes nucleated by GATA-1 and GATA-2. EMBO J 2004; 23:2841-2852.
56. Lahlil R, Lecuyer E, Herblot S, et al. SCL assembles a multifactorial complex that determines glycophorin A expression. Mol Cell Biol 2004; 24:1439-1452.
57. Goardon N, Lambert JA, Rodriguez P, et al. ETO2 coordinates cellular proliferation and differentiation during erythropoiesis. EMBO J 2006; 25:357-366.
58. Ema M, Faloon P, Zhang WJ, et al. Combinatorial effects of Flk1 and Tal1 on vascular and hematopoietic development in the mouse. Genes Dev 2003; 17:380-393.
59. Martin R, Lahlil R, Damert A, et al. SCL interacts with VEGF to suppress apoptosis at the onset of hematopoiesis. Development 2004; 131:693-702.
60. Condorelli G, Vitelli L, Valtieri M, et al. Coordinate expression and developmental role of Id2 protein and TAL1/E2A heterodimer in erythroid progenitor differentiation. Blood 1995; 86:164-175.
61. Bernard M, Delabesse E, Novault S, et al. Antiapoptotic effect of ectopic TAL1/SCL expression in a human leukemic T-cell line. Cancer Res 1998; 58:2680-2687.
62. Liao EC, Paw BH, Oates AC, et al. SCL/Tal-1 transcription factor acts downstream of cloche to specify hematopoietic and vascular progenitors in zebrafish. Genes Dev 1998; 12:621-626.
63. Caceres-Cortes JR, Krosl G, Tessier N, et al. Steel factor sustains SCL expression and the survival of purified CD34+ bone marrow cells in the absence of detectable cell differentiation. Stem Cells 2001; 19: 59-70.
64. Souroullas GP, Salmon JM, Sablitzky F, et al. Adult hematopoietic stem and progenitor cells require either Lyl1 or Scl for survival. Cell Stem Cell 2009; 4:180-186.
65. Venezia TA, Merchant AA, Ramos CA, et al. Molecular signatures of proliferation and quiescence in hematopoietic stem cells. PLoS Biol 2004; 2:e301.
66. Matthews W, Jordan CT, Gavin M, et al. A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. Proc Natl Acad Sci USA 1991; 88:9026-9030.
67. Fujiwara Y, Chang AN, Williams AM, et al. Functional overlap of GATA-1 and GATA-2 in primitive hematopoietic development. Blood 2004; 103:583-585.
68. Chan WY, Follows GA, Lacaud G, et al. The paralogous hematopoietic regulators Lyl1 and Scl are coregulated by Ets and GATA factors, but Lyl1 cannot rescue the early Scl-/- phenotype. Blood 2007; 109:1908-1916.
69. Robb L, Lyons I, Li R, et al. Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene. Proc Natl Acad Sci USA 1995; 92:7075-7079.
70. Sharma Y, Astle CM, Harrison DE. Heterozygous kit mutants with little or no apparent anemia exhibit large defects in overall hematopoietic stem cell function. Exp Hematol 2007; 35:214-220.
71. Tauchi T, Feng GS, Marshall MS, et al. The ubiquitously expressed Syp phosphatase interacts with c-kit and Grb2 in hematopoietic cells. J Biol Chem 1994; 269:25206-25211.
72. Xu D, Liu X, Yu WM, et al. Nonlineage/stage-restricted effects of a gain-offunction mutation in tyrosine phosphatase Ptpn11 (Shp2) on malignant transformation of hematopoietic cells. J Exp Med 2011; 208:1977-1988.
73. Chan G, Cheung LS, Yang W, et al. Essential role for Ptpn11 in survival of hematopoietic stem and progenitor cells. Blood 2011; 117:4253-4261.
74. Kent D, Copley M, Benz C, et al. Regulation of hematopoietic stem cells by the steel factor/KIT signaling pathway. Clin Cancer Res 2008; 14:1926-1930.
75. Hricik T, Federici G, Zeuner A, et al. Transcriptomic and phospho-proteomic analyzes of erythroblasts expanded in vitro from normal donors and from patients with polycythemia vera. Am J Hematol 2013; 88:723-729.